- Home
- NDRA vs VTAK Comparison
NDRA vs VTAK Comparison
Compare NDRA & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- VTAK
- Stock Information
- Founded
- NDRA 2007
- VTAK 2002
- Country
- NDRA United States
- VTAK United States
- Employees
- NDRA N/A
- VTAK N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VTAK Medical/Dental Instruments
- Sector
- NDRA Health Care
- VTAK Health Care
- Exchange
- NDRA Nasdaq
- VTAK Nasdaq
- Market Cap
- NDRA 4.6M
- VTAK 4.1M
- IPO Year
- NDRA 2017
- VTAK 2018
- Fundamental
- Price
- NDRA $5.01
- VTAK $2.44
- Analyst Decision
- NDRA Strong Buy
- VTAK
- Analyst Count
- NDRA 1
- VTAK 0
- Target Price
- NDRA $38.00
- VTAK N/A
- AVG Volume (30 Days)
- NDRA 798.9K
- VTAK 395.8K
- Earning Date
- NDRA 11-14-2025
- VTAK 11-14-2025
- Dividend Yield
- NDRA N/A
- VTAK N/A
- EPS Growth
- NDRA N/A
- VTAK N/A
- EPS
- NDRA N/A
- VTAK N/A
- Revenue
- NDRA N/A
- VTAK $600,000.00
- Revenue This Year
- NDRA N/A
- VTAK $822.86
- Revenue Next Year
- NDRA N/A
- VTAK $168.42
- P/E Ratio
- NDRA N/A
- VTAK N/A
- Revenue Growth
- NDRA N/A
- VTAK 37.62
- 52 Week Low
- NDRA $2.90
- VTAK $2.20
- 52 Week High
- NDRA $12.49
- VTAK $15.68
- Technical
- Relative Strength Index (RSI)
- NDRA 41.38
- VTAK 43.85
- Support Level
- NDRA $4.58
- VTAK $2.53
- Resistance Level
- NDRA $5.43
- VTAK $2.69
- Average True Range (ATR)
- NDRA 0.69
- VTAK 0.19
- MACD
- NDRA -0.24
- VTAK -0.04
- Stochastic Oscillator
- NDRA 8.19
- VTAK 2.78
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.